Related by context. All words. (Click for frequent words.) 66 prostate cancers 66 ductal carcinoma 63 malignancy 63 ovarian cancer 63 breast cancers 62 invasive breast cancer 60 atypia 60 breast tumors 60 ovarian tumors 59 adenocarcinoma 59 endometrial cancers 58 carcinoma 58 tumors 58 situ DCIS 58 invasive ductal carcinoma 57 lobular carcinoma 57 micrometastases 57 ovarian cancers 57 lobular cancer 57 prostate cancer 57 PCa 57 ALCL 56 colorectal cancers 56 HER2 positive 56 colorectal cancer 56 breast conserving 56 prostate tumors 55 thyroid nodules 55 epithelial ovarian cancer 55 atypical hyperplasia 55 breast lesions 55 HER2 positive breast cancer 55 invasive carcinoma 55 adenomas 55 breast cancer 55 metastatic cancer 55 lung cancers 55 cancerous breast 55 BRCA mutation carriers 55 gliomas 55 adenoma 54 prophylactic mastectomy 54 malignant tumors 54 neoplasia 54 rectal cancer 54 BRCA mutation 54 breast carcinoma 54 grade dysplasia 54 lymph node metastases 54 oophorectomy 54 NSCLC 54 gynecologic cancers 54 distant metastasis 53 estrogen receptor positive 53 seminoma 53 metastatic prostate cancer 53 distant metastases 53 situ LCIS 53 axillary dissection 53 pancreatic cancers 53 glioblastomas 53 ductal cancer 53 HER2 negative 53 benign tumors 53 BRCA mutations 53 localized prostate cancer 53 malignant lesions 53 malignant growths 53 HER2 positive cancers 53 tumor recurrence 53 cancers 53 adenocarcinomas 53 metastases 53 GISTs 53 bone metastasis 52 metastatic 52 neoadjuvant therapy 52 renal cell carcinoma 52 bowel cancers 52 HER2 positive tumors 52 metastasis 52 metastatic disease 52 bladder cancers 52 advanced adenoma 52 breast carcinomas 52 endometrial cancer 52 BRCA2 mutations 52 mucinous 52 lymph node involvement 52 melanoma 52 ovarian 52 neuroendocrine tumors 52 hormone receptor positive 52 tumor 52 renal cell carcinomas 52 pancreatic adenocarcinoma 52 ductal 52 adjuvant chemotherapy 52 invasive lobular carcinoma 52 CaP 52 lobular breast cancer 52 adenomatous polyps 52 sentinel nodes 52 prostate cancer CaP 52 BRCA1 52 lung tumors 52 colon cancers 52 prostate tumor 51 atypical ductal hyperplasia 51 lymph nodes 51 hormonal therapy 51 lymphomas 51 gastric cancer 51 estrogen receptor negative 51 invasive cervical cancer 51 advanced adenomas 51 endometrial 51 abnormal mammogram 51 medullary thyroid cancer 51 differentiated thyroid 51 papillary carcinoma 51 benign breast 51 urothelial carcinoma 51 peritoneal cancer 51 HGPIN 51 adjuvant radiation 51 medically inoperable 51 lymphoma 51 BRCA1 mutations 51 Tumors 51 sentinel node 51 seminomas 51 serous ovarian cancer 51 neoadjuvant chemotherapy 51 carcinomas 51 breast tissue 51 urothelial cancer 51 renal tumors 51 sentinel lymph node biopsy 51 papillary 51 ductal carcinomas 51 glioblastoma 51 thyroid cancers 50 malignant pleural mesothelioma 50 ductal breast cancer 50 tamoxifen therapy 50 pancreatic tumor 50 carcinoid tumors 50 lumpectomy 50 BRCA2 mutation carriers 50 operable breast cancer 50 radical nephrectomy 50 testicular cancers 50 polyps 50 lobular carcinomas 50 CIN2 + 50 fibroadenomas 50 uterine cancers 50 fibrocystic disease 50 malignancies 50 gynecologic cancer 50 fibroids 50 Ovarian cancer 50 benign polyps 50 uterine fibroid embolization 50 soft tissue sarcomas 50 precancerous cervical 50 placenta accreta 50 breast cancer recurrence 50 carcinoid 50 brain metastases 50 benign proliferative breast 50 lung nodules 50 sarcomatoid 50 neoplasms 50 preventive mastectomy 50 liver metastasis 50 bladder tumors 50 pancreatic tumors 50 DCIS lesions 50 squamous cell carcinomas 50 pre cancerous polyps 50 Ductal carcinoma 50 colorectal polyps 50 EUS FNA 50 invasive ductal 50 colorectal neoplasms 50 liver metastases 50 prostate cancer PCa 50 axillary lymph node dissection 50 cell carcinoma 50 EBRT 49 glandular tissue 49 Metastatic 49 pancreatic cancer 49 axillary lymph nodes 49 adjuvant therapy 49 colorectal cancer CRC 49 leiomyomas 49 epithelial ovarian 49 squamous cell cancers 49 melanomas 49 colorectal carcinoma 49 tamoxifen 49 HER2 49 preoperative chemotherapy 49 premenopausal 49 resectable 49 recurrent ovarian 49 thyroid cancer 49 hepatocellular carcinoma 49 Cristofanilli 49 sentinel node biopsy 49 adjuvant radiotherapy 49 surgical biopsy 49 incidentalomas 49 core needle biopsy 49 lymph node removal 49 pre cancerous lesions 49 cutaneous melanoma 49 sarcoma 49 hereditary breast cancer 49 benign growths 49 LCIS 49 malignant 49 metastatic tumors 49 grade gliomas 49 cancerous tissue 49 cervical carcinoma 49 ASCUS 49 brain tumors 49 squamous cell cancer 49 oropharyngeal cancer 49 anaplastic 49 cervical lesions 49 Inflammatory Breast Cancer 49 pCR 49 carcinoid tumor 49 colon cancer 49 HER2 positive metastatic breast 49 cT3 prostate cancer 49 pleural mesothelioma 49 CIN3 48 axillary nodes 48 Cholangiocarcinoma 48 extracolonic findings 48 benign lesions 48 polyp 48 precancerous 48 papillary thyroid cancer 48 Fibroids 48 HNSCC 48 Papillary 48 squamous cell carcinoma 48 cancerous lesions 48 contralateral breast 48 Digital Mammographic Imaging 48 prostate adenocarcinoma 48 metastatic lung cancer 48 lobules 48 infiltrating ductal carcinoma 48 carotid stenosis 48 locoregional recurrence 48 excisional biopsy 48 bladder cancer 48 metastatic lesions 48 uveal melanoma 48 ependymoma 48 colorectal liver metastases 48 varicoceles 48 Barrett esophagus 48 prostate specific antigen 48 lung cancer 48 PSA screening 48 lymph node dissection 48 basal cell carcinomas 48 squamous cell carcinoma SCC 48 cystectomy 48 Invasive Breast Cancer 48 GnRH agonists 48 gynecologic malignancy 48 histological subtype 48 metastatic breast cancer 48 papillary thyroid carcinoma 48 Testicular cancer 48 neoplasm 48 mastectomy 48 transitional cell carcinoma 48 milk ducts 48 renal carcinoma 48 orchiectomy 48 MALT lymphoma 48 testicular cancer 48 cancer 48 lymph node metastasis 48 overdiagnosis 48 ALND 48 cancerous cells 48 mesotheliomas 48 screening mammography 48 preventive mastectomies 48 oesophageal cancer 48 cytoreductive surgery 48 Polyps 48 meningioma 48 Inflammatory breast cancer 48 contralateral breast cancer 48 venous thromboembolism 47 PSA velocity 47 cancerous growths 47 endometrial carcinoma 47 melanoma tumors 47 abnormal cervical 47 premenopausal breast cancer 47 prophylactic mastectomies 47 histologic subtype 47 Adenocarcinoma 47 T1a 47 locoregional 47 BRCA deficient 47 endometrial tumors 47 ovarian tumor 47 Sentinel node biopsy 47 tumor subtypes 47 nodal metastases 47 BRCA1 gene 47 prostate specific 47 lymphovascular invasion 47 follicular lymphoma 47 Ductal Carcinoma 47 EGFR mutation 47 biochemical recurrence 47 colorectal tumors 47 melanoma lesions 47 radical prostatectomy 47 ovarian malignancy 47 nonmetastatic 47 noncancerous 47 gynecologic oncologists 47 gastric cancers 47 prostate cancer CRPC 47 rectal cancers 47 prostate tissue 47 HNPCC 47 prostate gland 47 axillary node dissection 47 Hurthle cell 47 pre cancerous lesion 47 basal cell 47 Renal cell carcinoma 47 precancer 47 precursor lesions 47 nonmelanoma skin cancers 47 meningiomas 47 cell lung cancer 47 atypical lobular hyperplasia 47 Wilms tumor 47 metastatic prostate 47 BRCA2 mutation 47 chemoradiation 47 colon tumors 47 colorectal adenomas 47 progesterone receptor negative 47 Carcinoma 47 synovial sarcoma 47 endometriosis 47 BRCA2 47 breast biopsies 47 Ewing sarcoma 47 Carcinoid tumors 47 ovaries removed 47 Pancreatic cancer 47 tumor shrinkage 47 B Cell Lymphoma 47 BRCA1 mutation 47 Lumpectomy 47 prostate biopsy 47 fibroid 47 screening mammogram 47 asymptomatic 47 tumor cells 47 pre menopausal 47 precancerous cervical lesions 47 polyp recurrence 47 elevated CRP 47 squamous cell skin 47 gynecological cancers 47 fine needle aspiration 47 HER2 amplification 47 metastatic renal cell carcinoma 47 intestinal metaplasia 47 esophageal adenocarcinoma 47 curable cancers 47 hysterectomy 47 endometrioid 47 uterine fibroids 47 Stat5 47 malignant gliomas 47 diagnostic mammograms 46 DLBCL 46 thymoma 46 BRCA 46 curative resection 46 preeclampsia 46 poorer prognosis 46 GBM tumors 46 mammographic density 46 breast MRIs 46 premalignant lesions 46 choriocarcinoma 46 liposarcoma 46 invasive lobular 46 PCNSL 46 cervical intraepithelial neoplasia 46 abnormal mammograms 46 hepatocellular carcinoma HCC 46 pre cancerous growths 46 peritoneal carcinomatosis 46 Rectal cancer 46 cytoreduction 46 hyperplastic polyps 46 NP CRNs 46 pelvic ultrasound 46 basal cell cancer 46 squamous cell lung cancer 46 ovary 46 colon polyps 46 GIST 46 endometrial hyperplasia 46 neoadjuvant 46 breast MRI 46 varicocele 46 bilateral oophorectomy 46 occult metastases 46 nodular melanoma 46 HER2 + 46 proximal colon 46 fibroadenoma 46 ovarian carcinoma 46 breast endometrial 46 prostatectomy 46 recurrent prostate cancer 46 osteosarcoma 46 malignant nodules 46 fallopian tube carcinoma 46 nonmelanoma skin cancer 46 BRCA1 mutation carriers 46 invasive ductal carcinomas 46 gastrointestinal cancers 46 calcifications 46 dysplasia 46 choroidal melanoma 46 SLNB 46 resected 46 pelvic lymph nodes 46 malignant lesion 46 premalignant 46 anthracyclines 46 Mastectomy 46 BSGI 46 precancerous spots 46 Glioblastoma 46 metastatic melanoma 46 serum PSA 46 testicular germ cell 46 Hepatocellular Carcinoma HCC 46 pre cancerous 46 Malignant tumors 46 abnormal cytology 46 precancerous lesions 46 ductal lavage 46 nephrectomy 46 NAFLD 46 colorectum 46 basal cell carcinoma 46 leiomyosarcoma 46 Uterine fibroids 46 lymph node 46 cancerous enlargement 46 esophagectomy 46 Fibroid 46 ccRCC 46 contralateral prophylactic mastectomy 46 precancerous condition 46 GIST tumors 46 KRAS wild 46 recurrent NSCLC 46 hormone receptor negative 46 untreated celiac disease 46 grade cervical intraepithelial 46 Radical prostatectomy 45 squamous cell 45 oesophageal adenocarcinoma 45 malignant prostate 45 BRCA2 carriers 45 cysts 45 nonproliferative 45 sentinel lymph node 45 basal cell carcinoma BCC 45 pleomorphic 45 catheter angiography 45 cisplatin resistant 45 epithelial tumors 45 follicular thyroid cancer 45 lobular 45 advanced neoplasia 45 Tumours 45 MGUS 45 needle biopsy 45 pituitary adenomas 45 gastric carcinoma 45 glioma 45 leukaemias 45 lung metastasis 45 Basal cell 45 #.#ng/ml 45 thyroid nodule 45 BRCA gene mutation 45 androgen deprivation 45 adenomatous 45 grade glioma 45 dense breasts 45 benign noncancerous 45 ductal lobular 45 pancreatic NET 45 breast cancer susceptibility genes 45 salpingo oophorectomy 45 paragangliomas 45 colorectal polyp 45 pituitary adenoma 45 histologically confirmed 45 cervical cancer 45 invasive ductal breast cancer 45 mediastinoscopy 45 Metastases 45 mammographic screening 45 recurrent ovarian cancer 45 molar pregnancy 45 uterine ovarian 45 gastric adenocarcinoma 45 Tamoxifen 45 BRCA gene mutations 45 pelvic lymphadenectomy 45 esophageal cancer 45 sentinel lymph nodes 45 micrometastasis 45 Breast Cancer Risk 45 thyroglobulin 45 hamartomas 45 metastatic colorectal cancer 45 medulloblastoma 45 cystic 45 carcinoid cancer 45 Colorectal 45 specific antigen 45 metastatic GIST 45 allogeneic stem cell 45 Bladder cancer 45 nonsmall cell lung cancer 45 malignant melanoma 45 gynecologic oncologist 45 esophageal squamous cell carcinoma 45 pre cancerous cells 45 core needle biopsies 45 Basal cell carcinoma 45 hormone receptor status 45 intraductal 45 mammographically 45 CIN2 45 HRPC 45 benign nodules 45 preventative mastectomy 45 testicular tumors 45 intraepithelial neoplasia 45 acoustic neuromas 45 clinically insignificant 45 teratoma 45 retinoblastoma 45 metastatic ovarian cancer 45 vulvar intraepithelial neoplasia 45 CT colonography 45 indolent lymphoma 45 NMP# 45 lung adenocarcinomas 45 surgical excision 45 B7 H3 45 oncologic outcomes 45 malignant cells 45 malignant polyps 45 biopsies 45 aromatase 45 axillary lymph node 45 neoadjuvant treatment 45 undergoing hysterectomy 45 malignant neoplasm 45 clinically localized prostate 45 ovarian hyperstimulation syndrome OHSS 45 postmenopausal breast cancer 45 tumoral 45 uterine tumors 45 Prostate cancer 45 pancreatic 45 Barrett Esophagus 45 pelvic malignancies 45 pancreatic lung 45 NMIBC 45 Glioma 45 thyroid carcinoma 45 uterine rupture 45 basal cell cancers 45 premenopausal women 45 Acute myeloid leukemia 45 gastrointestinal stromal tumor 45 gastric cardia 45 KRAS mutation 45 distal colon 45 HPV infection 45 postoperative pathology 44 anastrozole 44 mammographic 44 endoscopic ultrasound 44 chemoprevention 44 fibrocystic 44 radical prostatectomy RP 44 tumor histology 44 denser breasts 44 ovarian lung 44 metastatic lesion 44 uterine cancer 44 pulmonary metastases 44 breast ovarian 44 lymphatic tissue 44 lymphadenectomy 44 hepatocellular cancer 44 ovarian hyperstimulation 44 hematopoietic cancers 44 dysplastic 44 hormone refractory 44 Squamous 44 sarcosine 44 cancerous 44 antigen PSA 44 dutasteride 44 axillary node 44 malignant ovarian 44 prostate bladder 44 gastrectomy 44 polycythemia vera 44 DCIS ductal carcinoma 44 biopsy 44 chemoembolization 44 metastatic gastric 44 non Hodgkin lymphoma 44 fibrocystic changes 44 cervical cancers 44 precancerous polyp 44 nodule 44 surgical biopsies 44 precancerous polyps 44 prostate biopsies 44 Dr Zorbas 44 pheochromocytomas 44 postmenopausal women 44 situ CIS 44 node metastases 44 metastatic tumor 44 Thyroid cancer 44 familial pancreatic cancer 44 mCRC patients 44 mastectomies 44 prostate carcinoma 44 microcalcifications 44 resistant ovarian cancer 44 cisplatin 44 colorectal 44 CLL 44 neuroendocrine cancers 44 BRCA carriers 44 eribulin 44 chlamydial infection 44 SPINK1 44 Endometrial cancer 44 metastatic breast 44 EGFR mutations 44 total thyroidectomy 44 postoperative radiotherapy 44 tumor resection 44 angiosarcoma 44 skin sparing mastectomy 44 invasive diagnostic 44 SUVmax 44 mammographic breast density 44 postoperative mortality 44 systemic scleroderma 44 colorectal gastric 44 autoantibodies 44 Breast cancer 44 laryngeal cancer 44 superficial bladder cancer 44 Seewaldt 44 pneumonectomy 44 HER2 overexpression 44 HER-2/neu 44 lung adenocarcinoma 44 ovarian function 44 malignant tumor 44 papillary renal cell carcinoma 44 lymph node biopsies 44 prostate 44 follicular lymphomas 44 ipsilateral breast 44 partial nephrectomy 44 gynecological cancer 44 Malignant Melanoma 44 lymphoproliferative disorders 44 invasive bladder 44 Adjuvant chemotherapy 44 Endometrial 44 mammary tumors 44 Screening mammography 44 Lymph node 44 microscopic hematuria 44 smoldering myeloma 44 ErbB2 positive 44 precancerous tumors 44 Accelerated Partial Breast Irradiation 44 pancreatic carcinoma 44 KRAS mutations 44 glioblastoma multiforme 44 Pancreatic neuroendocrine tumors 44 esophagogastric junction 44 aneuploid cells 44 skin cancers 44 hormone deprivation 44 mutated BRAF gene 44 vertebral fracture 44 CIN3 + 44 Colon polyps 44 para aortic 44 pancreatic cysts 44 mutated KRAS gene 44 neoplasia PIN 44 neoplastic 44 prostatic adenocarcinoma 44 TURP 44 postoperative chemotherapy 44 Ovarian 44 PKCi 44 MetS 44 metastatic malignant melanoma 44 intraperitoneal therapy 44 Screening Trial DMIST 44 ectopic pregnancy 44 pre malignant lesions 44 glioma tumors 44 ependymomas 44 lymphocytosis 44 genistein 44 PSADT 44 osteosarcomas 44 inherited gene mutation 44 ductal adenocarcinoma 44 baseline mammogram 44 polycystic ovary syndrome PCOS 44 acute myelogenous leukemia AML 44 neoplasias 44 lung nodule 44 Anal cancer 43 Anaplastic 43 frequently benign tumor 43 colon adenomas 43 Her2 43 cancerous lesion 43 peritoneal 43 lesions 43 alveolar rhabdomyosarcoma 43 biopsied 43 cranial radiation 43 NKX2 43 noncancerous growths 43 premalignant lesion 43 thyroidectomy 43 watchful waiting 43 JMML 43 molecular subtypes 43 multiple gestations 43 colon polyp 43 chemoresistant 43 chromosomal abnormalities 43 androgen deprivation therapy 43 ADPKD 43 Metastasis 43 malignant cancerous 43 Lung cancer 43 nodal metastasis 43 ARVD 43 Glioblastoma Multiforme GBM 43 Pap smear 43 radiation therapy SBRT 43 dysplastic nevi 43 spontaneous regression 43 breast caner 43 Epithelial ovarian cancer 43 embryonal rhabdomyosarcoma 43 myomectomy 43 Glioblastoma Multiforme 43 metastatic liver 43 nonalcoholic steatohepatitis NASH 43 resection 43 colonoscopy screenings 43 hormone therapy estrogen 43 SLN biopsy 43 ErbB2 43 SBRT 43 metastatic colon cancer 43 undergone radical prostatectomy 43 bowel cancer 43 hormone therapy 43 Esophageal Cancer 43 malignant melanomas 43 recurrent colorectal cancer 43 Follicular lymphoma 43 paraganglioma 43 bowel polyps 43 luminal cells 43 estrogen therapy 43 hepatic metastases 43 cutaneous squamous cell carcinoma 43 metachronous 43 nodal dissection 43 gastrointestinal stromal tumors 43 primitive neuroectodermal tumor 43 lymphedema 43 cancerdefine 43 EBUS FNA 43 metastatic carcinoma 43 myoepithelial 43 mutated BRCA1 43 chromophobe 43 Smith Bindman 43 carcinoma HNSCC 43 aromatase inhibitors 43 radiation therapy 43 serrated polyps 43 mammography 43 extracapsular extension 43 cervical lymph node 43 olaparib 43 androgen suppression therapy 43 noncancerous tumors 43 cell carcinomas 43 pre eclampsia 43 premature menopause 43 Adenomas 43 subclinical hypothyroidism 43 lobular involution 43 gestational diabetes 43 debulking surgery 43 CMV infection 43 colorectal adenoma 43 Metastatic colorectal cancer 43 symptomatic fibroids 43 histopathologic 43 precancerous cells 43 oligodendrogliomas 43 polypoid lesions 43 Androgen deprivation therapy 43 undergo lumpectomy 43 nephron sparing surgery 43 pulmonary nodules 43 acinar cells 43 histologically 43 bilateral mastectomy 43 T1c 43 chondrosarcoma 43 recurrent VTE 43 FDG uptake 43 lung pancreatic 43 letrozole 43 CMV disease 43 epithelioid 43 esophageal cancers 43 neoplastic lesions 43 inherited mutations 43 virtual colonography 43 cancerous lymph nodes 43 bevacizumab 43 neuroblastoma 43 recurrence 43 prognostic variables 43 hamartoma 43 Follicular Lymphoma 43 liver cancer 43 breast lumps 43 precancers 43 EGFR 43 genes BRCA1 43 diverticulosis 43 squamous histology 43 HPV infections 43 invasive coronary angiography 43 underwent brachytherapy 43 LRP6 43 Glioblastoma multiforme GBM 43 ovulation induction 43 hormonal therapies 43 underarm lymph nodes 43 metastatic lymph nodes 43 gynecological malignancies 43 nephrogenic 43 neuroblastoma tumor 43 pT2 43 Breast Cancers 43 gallstone disease 43 stage IIIA 43 faulty BRCA genes 43 yearly mammograms 43 R0 resection 43 Malignant gliomas 43 lumpectomies 43 desmoid tumor 43 urine cytology 43 malignant lymph nodes 43 colon rectal cancer 43 undergone hysterectomy 43 familial ALS 43 colposcopy 43 adjuvant therapies 43 thymic carcinoma 43 osteoporotic 43 oral squamous cell 43 metastatic colorectal 43 specific antigen PSA 43 needle biopsies 43 Hodgkin disease 43 FDG-PET/CT 43 yearly mammogram 43 screening mammograms 43 noncancerous cells 43 metastatic RCC 43 endosonography 43 cancerous tumors 43 histologies 43 histologic 43 prognostic biomarker 43 colectomy 43 multimodality therapy 43 ocular melanoma 43 relapsed GBM 43 chronic bilirubin encephalopathy 43 endocrine tumors 43 HER2 gene 43 hepatectomy 43 ovaries 43 neuroendocrine carcinoma 43 nonseminoma 43 anal lesions 43 cancerous polyps 43 postmenopausal hormones 43 astrocytomas 43 Polycythemia vera 43 GBMs 43 chronic prostatitis 43 androgen independent 43 malignant neoplasms 43 vulvar cancer 43 vestibular schwannomas 43 tibolone 43 acute leukemias 43 Sarcomas 43 intestinal polyps 43 invasive aspergillosis 43 TMPRSS2 ERG fusion 43 mammograms 43 chromosomal rearrangement 43 upper endoscopy 43 VUR 43 unresectable 43 variceal hemorrhage 43 breast conserving lumpectomy 43 supratentorial 43 HER2 expression 43 keloid 42 Uterine cancer 42 low expressors 42 Ovary removal 42 BRAF mutation 42 haematological cancers 42 antitumor effect 42 KRAS status 42 gastrointestinal stromal tumor GIST 42 ERCC1 42 polycystic ovarian syndrome PCOS 42 hyperplastic 42 serum prostate 42 response pCR 42 routine mammograms 42 PARP inhibition 42 diabetes mellitus DM